Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Toronto

$135,000.00

Uncovering the transcriptional regulatory networks that control uterine contraction to identify novel therapeutic targets in preventing pre-term birth

EF 2020-21

Résumé
One in ten babies are born early (pre-term), underdeveloped and at high risk of complications or death. The impact of being born prematurely can continue to effect individuals much later in life, costing Canada ~$2 billion annually and imposing emotional and physical burdens on those involved. Term and pre-term delivery of infants occurs in the same manner, the smooth muscle component of the uterus (myometrium) contracts to generate a force that expels the fetus. This contraction is controlled at the cellular level with individual muscle cells of the myometrium activating a group of genes that promote this contraction. How exactly these genes are regulated to induce contractile forces at term or pre-term is unknown. There are currently no treatments for pre-term labour. Therefore, understanding how these genes are regulated will be essential in providing new treatments to prevent pre-term birth. Genes can be regulated by proteins that interact with regions of DNA in the genome to turn on/off expression. We will be the first to identify differences between proteins binding in pre-term and term labour, with these proteins providing potential therapeutic targets. Another manner in which genes can be regulated is the result of how the genome is folded three-dimensionally in the nucleus. This three-dimensional structure enables different regions of the genome to come into contact with one another, regulating if a gene is on or off. This organization is cell-type specific and contributes to a cells specific function. Genome organization of the myometrium and regulation of genes in pregnancy and labour is also unknown. By determining this organization, alongside identification of regulatory proteins, it will be possible to construct a model by which pre-term labour occurs, and provide novel targets for the development of treatments to prevent preterm labour.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
441108
Name
Gillespie Zoe E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Uncovering the transcriptional regulatory networks that control uterine contraction to identify novel therapeutic targets in preventing pre-term birth
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Epigenetics; Gene Regulation; Genome Organization; Myometrium; Pregnancy; Transcriptional Regulation; Transcriptomics
Abstract
One in ten babies are born early (pre-term), underdeveloped and at high risk of complications or death. The impact of being born prematurely can continue to effect individuals much later in life, costing Canada ~$2 billion annually and imposing emotional and physical burdens on those involved. Term and pre-term delivery of infants occurs in the same manner, the smooth muscle component of the uterus (myometrium) contracts to generate a force that expels the fetus. This contraction is controlled at the cellular level with individual muscle cells of the myometrium activating a group of genes that promote this contraction. How exactly these genes are regulated to induce contractile forces at term or pre-term is unknown. There are currently no treatments for pre-term labour. Therefore, understanding how these genes are regulated will be essential in providing new treatments to prevent pre-term birth. Genes can be regulated by proteins that interact with regions of DNA in the genome to turn on/off expression. We will be the first to identify differences between proteins binding in pre-term and term labour, with these proteins providing potential therapeutic targets. Another manner in which genes can be regulated is the result of how the genome is folded three-dimensionally in the nucleus. This three-dimensional structure enables different regions of the genome to come into contact with one another, regulating if a gene is on or off. This organization is cell-type specific and contributes to a cells specific function. Genome organization of the myometrium and regulation of genes in pregnancy and labour is also unknown. By determining this organization, alongside identification of regulatory proteins, it will be possible to construct a model by which pre-term labour occurs, and provide novel targets for the development of treatments to prevent preterm labour.
Competitiondate
202012
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gillespie, Zoe E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~